Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists
US-12383521-B2 · Aug 12, 2025 · US
Io Therapeutics Inc holds 171 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 171 |
| Recent patents | 23 |
| First publication | Feb 5, 2015 |
| Latest publication | Aug 12, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12383521-B2 · Aug 12, 2025 · US
US-2025248962-A1 · Aug 7, 2025 · US
US-12325685-B2 · Jun 10, 2025 · US
US-2025026714-A1 · Jan 23, 2025 · US
US-12115193-B2 · Oct 15, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12383521-B2 · Aug 12, 2025 · US
US-2025248962-A1 · Aug 7, 2025 · US
US-12325685-B2 · Jun 10, 2025 · US
US-2025026714-A1 · Jan 23, 2025 · US
US-12115193-B2 · Oct 15, 2024 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 171 |
| Chemistry & Metallurgy | 84 |
| Cross-Sectional Technologies | 68 |
Answers are generated from the same data shown on this page.